Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CHRNA1 Polyclonal Antibody

Catalog #:   PHB99602 Specific References (15) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P02708
Overview

Catalog No.

PHB99602

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CHRNA1 (Gly20-Leu255).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

ACHRA, Acetylcholine receptor subunit alpha, CHRNA1, CHNRA

Purification

Purified by antigen affinity column.

Accession

P02708

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CHRNA1 antibody (PHB99602) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 29 kDa
    Observed MW: 29 kDa
References

Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study., PMID:40279038

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization., PMID:36979710

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study., PMID:35074870

Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis., PMID:31855720

Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis., PMID:30696470

MTOR signaling is essential for the development of thymic epithelial cells and the induction of central immune tolerance., PMID:29099279

Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications., PMID:28440223

Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms., PMID:28364296

Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis., PMID:27501803

Neuronal control of localized inflammation through expressed nicotinic acetylcholine receptors: a study carried out in mice., PMID:26778394

Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis., PMID:24667415

Expression of a highly antigenic and native-like folded extracellular domain of the human α1 subunit of muscle nicotinic acetylcholine receptor, suitable for use in antigen specific therapies for Myasthenia Gravis., PMID:24376846

The α1 subunit of nicotinic acetylcholine receptors in the inner ear: transcriptional regulation by ATOH1 and co-expression with the γ subunit in hair cells., PMID:17961150

An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus., PMID:17687331

Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man., PMID:12935778

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CHRNA1 Polyclonal Antibody [PHB99602]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only